Investors await Akebia's Q1 2026 financial results, focusing on revenue trends and operational performance in the biopharmaceutical sector. Akebia is scheduled to release its Q1 2026 earnings, with analysts closely monitoring revenue figures and pipeline developments. The
CVS Health projects at least $405 billion in revenue by 2026 while targeting adjusted earnings per share between $7.30 and $7.50. CVS Health unveiled its 2026 financial outlook, targeting adjusted earnings per share of $7.30 to $7.50. The company also aims for at least $40
Investors await Vericel's Q1 2026 financial results, with focus on revenue trends and product pipeline performance. Vericel is scheduled to release its Q1 2026 earnings report, with analysts closely monitoring revenue growth and operational metrics. The company’s performan
Hopes of a deal are high once more, as US earnings continue to impress The Middle East conflict is dominating sentiment on Wednesday, oil prices are plunging and stocks are being led higher by European shares, which are surging. US indices are also extending gains above Tu
Investors await the company’s first-quarter earnings amid recent sector volatility and shifting mortgage demand. Better Home & Finance Holding will release its Q1 2026 earnings report, a closely watched event for mortgage and housing finance markets. The results come as th
Investors await Nuveen Churchill Direct Lending's Q1 2026 financial results amid shifting credit market conditions. Nuveen Churchill Direct Lending is preparing to report its Q1 2026 earnings, a key indicator for private credit performance. The firm’s results will reflect
Investors await Insmed's Q1 2026 financial results, focusing on revenue trends and pipeline developments in rare disease treatments. Insmed is scheduled to release its Q1 2026 earnings, with analysts closely monitoring revenue performance. The biopharmaceutical firm has be
FOA reports Q1 2026 earnings with revenue growth offset by rising operational costs and macroeconomic pressures. FOA announced Q1 2026 earnings, revealing a 4.2% year-over-year revenue increase to $2.1 billion, driven by higher trading volumes in emerging markets. However,
Lumentum reports Q3 2026 earnings Lumentum has released its Q3 2026 earnings transcript. The earnings report provides insight into the company's performance during the period. No specific details on the earnings are available as the transcript has been released w
Investors await Middleby's Q1 2026 financial results amid mixed sector performance and supply chain challenges. Middleby is set to release its Q1 2026 earnings report, with analysts closely monitoring performance amid ongoing supply chain disruptions and fluctuating demand
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.